Eyeworld

by Title ASCRS NEWS Heading Name title Contact Name: email EyeWorld: What has your experience been like performing charitable surgery, and what would you say to surgeons considering volunteering? Dr. Al-Mohtaseb: Operation Sight has become an incred- ible resource for patients across the U.S., and under the leadership of Sarah Duval, Operation Sight Program Man- ager and Communications Liaison, the program has built an outstanding system that makes volunteering remarkably easy for surgeons. The ASCRS Foundation coordinates the patient screening, logistics, and support, allowing surgeons to focus on what they do best—restoring sight. Whether you can volunteer for one surgery a year or many each month, the program is designed to fit whatever level of commitment works for your practice. I would encourage every ASCRS member to become a volunteer surgeon. Once you experience the impact that restoring sight has on their life, you'll understand why this work is so meaningful. Anyone interested in learning more or volunteering can visit the Operation Sight website at operationsightusa.org. EyeWorld: Do you have any particular goals or initiatives as the new Chair? Dr. Al-Mohtaseb: One of my biggest priorities is expanding the ASCRS Foundation's humanitarian impact, both glob- ally and here at home. Internationally, we are developing a centralized global mission initiative that will help visual- ize where humanitarian ophthalmic work is taking place around the world. Many organizations are doing extraor- dinary work, but efforts are often fragmented. By creating a coordinated view of global outreach, we can reduce du- plication, identify underserved regions, build partnerships, and maximize the impact of our collective efforts. Domestically, the need continues to grow. This year alone, Operation Sight has seen approximately twice as many patient inquiries compared with last year. That tells us there are still thousands of patients in the U.S. who lack access to sight-restoring care. 12 | EYEWORLD | FALL 2026 IMPORTANT PRODUCT INFORMATION ARGOS ® Optical Biometer Caution: Federal (USA) law restricts this device to the sale by or on the order of a physician. Indications: ARGOS ® is a non-invasive, non-contact biometer based on swept-source optical coherence tomography (SS-OCT). The device is intended to acquire ocular measurements as well as perform calculations to determine the appropriate intraocular lens (IOL) power and type for implantation during intraocular lens placement. Intended Use: The Reference Image functionality is intended for use as a preoperative and postoperative image capture tool. It is intended for use by ophthalmologists, physicians, and other eye- care professionals and may only be used under the supervision of a physician. Warnings and Precautions: • Only properly trained personnel with experience may operate the device and control software and interpret the results. • Factors that influence the measurement of patient's eyes are listed in the User Manual (Table 1): pseudophakic eye, wearing contact lenses, fixation problem, cornea opacity, non-intact cornea, refractive surgery, blood in the vitreous humor, retinal detachment, keratoconus, asteroid hyalosis, ambient light in the room, and deformation of the corneal shape. Please consider the guidance provided in Table 1 when you encounter these factors. • Optical Radiation - This device is equipped with a Class 1 laser light source. ATTENTION: Refer to the ARGOS ® User Manual for a complete description of proper use and maintenance, optical and technical specifications, as well as a complete list of warnings and precautions. © 2026 Alcon Inc. US-ARB-2600001 continued from page 6 ASCRS position statement on cyclodialysis with scleral reinforcement ASCRS has released a position statement addressing how physicians should report a controlled cyclodialysis with scleral reinforcement procedure using currently available CPT codes— until a dedicated Category III code takes effect on January 1, 2027. Scan the QR code to read the full position statement, and look for more on this in the Winter issue of EyeWorld.

• Cover